November 11, 2020
1st Patient Treated in Phase 3 Trial of RDEB Gene Therapy, D-Fi
Read MoreOctober 29, 2020
Castle Creek Biosciences’ D-Fi To Be Manufactured At In-House cGMP
Read MoreOctober 20, 2020
First Patient Treated in Trial Testing FCX-013 Gene Therapy for Localized Scleroderma
Read MoreMay 09, 2020
9 Philly Companies on the Cutting Edge of Cell and Gene Therapy Innovation
Read MoreFebruary 29, 2020
NextUp: “The Company Using Gene Therapy to Cure Rare Skin Conditions” John Maslowski, CEO, Castle Creek Biosciences
Read MoreJanuary 02, 2020
“Acquisition Combines Two Pipelines for Rare Skin Diseases” John Maslowski, CEO, Castle Creek Biosciences
Read More